Helicobacter pylori infection in symptomatic patients with benign gastroduodenal diseases. Analysis of 5.664 cases;Infección por Helicobacter pylori en pacientes sintomáticos con patología gastroduodenal benigna. Análisis de 5.664 pacientes

Revista Medica de Chile

Volumn 138, Issue 5, 2010, Pages 529-535

  Ortega, Juan Pablo ^a   Espino, Alberto ^b   Calvo B , Alfonso ^c   Verdugo, Patricia ^c   Pruyas, Martha ^a   Nilsen, Eva ^a   Villarroel, Luis ^d   Padilla, Oslando ^d   Riquelme, Arnoldo ^b   Rollán, Antonio ^e  

^a HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Centro de Referencia de Salud San Rafael La Florida   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Epidemiology; Gastroscopy; Helicobacter pylori; Peptic ulcer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIOPSY; CHILE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PEPTIC ULCER; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICS; STOMACH MUCOSA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; CHILE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77954677419     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
2. Johannes GK, Arnoud HM, Ernst JK. Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 2006; 19: 449-90.
3. Valenzuela EJ. Helicobacter pylori: La revolución bacteriológica. Rev Med Chile 1999; 127: 891-3.
4. Ferreccio C, Rollán A, Harris PR, Serrano C, Gederlini A, Margozzini P, et al. Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country. Cancer Epidemiol Biomarkers Prev 2007; 16: 662-7.
5. Rathbone BJ, Wyatt JL, Heatley RV. Campylobacter pyloridis: a new factor in peptic ulcer disease? Gut 1986; 27: 635-41.
6. Tygat G, Dixon MF. Overview. In: Northfield TC, Mendalí M, Goggin PM, editors. Helicobacter pylori infection. Pathophysiology, Epidemiology and Management. London: Kluwer Academic Publishers 1993; p. 75-87.
7. Mitani K, Tatsut M, Iishi, Yano H, Uedo N, Iseki K, Narahara H. Helicobacter pylori infection as a risk factor for gastric ulceration. Hepatogastroenterology 2004; 51: 309-12.
8. Rollán A, Giancaspero R, Fuster F, Acevedo C, Figueroa C, Hola K, et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am J Gastroenterol 2000; 95: 50-6.
9. Weston AP, Badr AS, Topalovski, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagous, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-94.
10. Raghunath AS, Hungin AP, Wooff D, Childs S. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther 2004; 20: 733-44.
11. Abe Y, Ohara S, Koike T, Sekine H, Iijima K, Kawamura M, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol 2004; 99: 1213-21.
12. Talley NJ, Vakil N, Ballard D, Fennery MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl Med 1999; 341: 1106-11.
13. Laine L, Shoenfeld P, Fennetry MB. Therapy for H. pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized controlled trials. Ann Intern Med 2001; 134: 361-9.
14. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; CD002096. Disponible en: www.cochrane.org [Consultado el 20 de septiembre de 2009].
15. Gwee KA, Leyan T, Wong RK, Ho KY, Sutedja DS, Yeoh KG. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2009; 21: 417-24.
16. Calvo A, Pruyas M, Nielsen E, Verdugo P. Pesquisa poblacional de cáncer gástrico en pacientes sintomáticos digestivos, período 1996-2000. Rev Med Chile 2001; 129: 749-55.
17. Viiala CH, Windsor H, Forbes G, Chairman SO, Mollison LC. Evaluation of a new formulation CLOtest. J Gastroenterol Hepatol 2002; 17: 127-30.
18. Ronkainen J, Aro P, Storskrubb T, Johanson SE, Lind T, Bolling-Sternevald E, et al. High prevalence of gastroesophageal refl ux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-85.
19. Leong RW. Differences in peptic ulcer between the East and the West. Gastroenterol Clin North Am 2009; 38:363-79.
20. Nimish V, Francis M. Eradication Therapy for Helicobacter pylori. Gastroenterology 2007; 133: 985-1001.
21. Zhang CH, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005; 11: 791-6.
22. Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51:15-20.
23. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Aplleman MD, Pérez-Pérez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321; 1562-6.
24. Hansson LE, Nyrén O, Hsing AW, Bergström R, Josefsso S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
25. Rollan A, Ferreccio C, Gederlini A, Serrano A, Torres J, Harris P. Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12: 7172-8.